These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 326043)
21. Consequences of renal insufficiency on the hepatic clearance of some drugs. Balant LP; Dayer P; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317 [TBL] [Abstract][Full Text] [Related]
22. [Prescription of drugs in liver diseases]. Held H Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474 [No Abstract] [Full Text] [Related]
23. [The importance of the biliary excretion of drugs in the human]. Siegers CP; Klaassen CD Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227 [No Abstract] [Full Text] [Related]
24. [Dose adaptation of drugs for liver patients using a simple risk classification]. Zysset T; Bircher J Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941 [No Abstract] [Full Text] [Related]
25. Effects of liver disease on drug disposition in man. Wilkinson GR; Schenker S Biochem Pharmacol; 1976 Dec; 25(24):2675-81. PubMed ID: 795432 [No Abstract] [Full Text] [Related]
30. Prescribing in patients with abnormal liver function tests. Smith E; Desmond P Aust Fam Physician; 2013; 42(1-2):30-3. PubMed ID: 23529456 [TBL] [Abstract][Full Text] [Related]
31. Drug metabolism and liver disease in India. Narang AP; Kaur U; Bambery P Drug Metab Rev; 1991; 23(1-2):65-81. PubMed ID: 1868778 [No Abstract] [Full Text] [Related]
33. The application of clearance concepts to propranolol disposition in man. Wilkinson GR Drug Metab Rev; 1979; 10(1):107-23. PubMed ID: 393480 [No Abstract] [Full Text] [Related]
34. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references. Pagliaro LA; Benet LZ J Pharmacokinet Biopharm; 1975 Oct; 3(5):333-83. PubMed ID: 1107513 [No Abstract] [Full Text] [Related]
35. [Clinical significance of disorders of drug kinetics in liver diseases]. Bolanowski M; Orzechowska-Juzwenko K Pol Arch Med Wewn; 1986 Apr; 75(4):288-96. PubMed ID: 3540881 [No Abstract] [Full Text] [Related]
37. Some clinical features of liver cell failure: an appraisal of their causes. Read AE Gut; 1978 Jun; 19(6):543-8. PubMed ID: 355067 [TBL] [Abstract][Full Text] [Related]
38. Genetic and environmental factors affecting drug disposition in man. Vesell ES Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):659-79. PubMed ID: 334437 [No Abstract] [Full Text] [Related]
39. Guide to drug dosage in hepatic disease. Bass NM; Williams RL Clin Pharmacokinet; 1988 Dec; 15(6):396-420. PubMed ID: 3072141 [No Abstract] [Full Text] [Related]
40. Biological half-lives of chemicals in fishes. Niimi AJ Rev Environ Contam Toxicol; 1987; 99():1-46. PubMed ID: 3303179 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]